The CEO of a device startup shared his team's surprises and alliance lessons learned in this ASAP BioPharma Conference 2021 day two keynote. Continue Reading
Fundamental partnering practices combined with a modern digital platform will boost value realization, operational efficiency, risk management, and strategic agility across the portfolio, according to allianceboard's Digital Alliance Maturity Index. Continue Reading
In biopharma today, it's all about collaboration and putting the patient at the center. Two CEOs discussed how their partnership thrives on openness, trust, and shared goals and how it continually keeps the focus on patient needs. Continue Reading
The 2021 ASAP BioPharma Conference panel “Partnering for Patient Impact” revealed some ways alliance managers can create a patient-focused culture across their portfolios, measure the impact alliances have on patients, and foster innovations that can directly improve patient experiences. Continue Reading
The collaboration between Halozyme and argenx is a powerful combination. The two companies' CEOs will tell how and why it works and why such partnerships are more important than ever in an increasingly patient-centric pandemic world. Continue Reading
Alliance portfolios are at the center of business models that directly impact innovation. Portal Instruments CEO Patrick Anquetil, will reveal his company’s alliance-centric model is developing needle-free injections at the 2021 ASAP BioPharma Conference. Continue Reading
Everybody is now expected to operate with the patient front and center in their minds—including alliance managers, which is necessitating a shift in how they select partners, devise alliance strategy, and execute collaborations. Continue Reading
Patients and Precision: 2021 ASAP BioPharma Conference Explores Collaboration in the Increasingly Digital World of Healthcare As we emerge from the pandemic, the biopharmaceutical industry is faced with a variety of challenges old and new—and some old ones with a new twist. The industry... Continue Reading
Posted By Jon Lavietes, Wednesday, November 25, 2020 Biopharma alliances have been steadily growing in number and complexity. In the early drug development phases, companies are shifting R&D responsibilities to an increasingly diverse array of CROs, academic institutions, startups,... Continue Reading
Posted By Jon Lavietes, Friday, November 20, 2020 Groundbreaking medical treatments come in many forms. The average person is likely to associate the pharmaceutical industry’s role in healing with prescription and over-the-counter drugs. While the pills, capsules, tablets, and liquids they... Continue Reading
Posted By Jon Lavietes, Monday, October 19, 2020 Clinical trials have undergone a bit of a transformation in recent years. Much like what has happened with pharmaceutical manufacturing operations over the last decade and more, clinical trial site management is becoming less transactional and more... Continue Reading
Posted By Michael J. Burke, Monday, October 5, 2020 The road to digital health has been paved with good intentions: it’s about helping people take charge of their own health and wellness, after all. But it’s been a rocky road as well, and for pharma and tech companies taking the trip... Continue Reading
